Literature DB >> 3821810

Hypocalciuria in preeclampsia.

P A Taufield, K L Ales, L M Resnick, M L Druzin, J M Gertner, J H Laragh.   

Abstract

We studied 40 women in the third trimester of pregnancy to determine whether alterations in serum calcium levels or in urinary calcium excretion would distinguish patients with preeclampsia from normal pregnant women or women with other forms of gestational hypertension. Our population included 10 normal pregnant women, 5 pregnant women with transient hypertension, 6 with chronic hypertension, 7 with chronic hypertension and superimposed preeclampsia, and 12 with preeclampsia. The serum levels of ionized calcium, phosphate, and 1,25-dihydroxyvitamin D were not different among the various groups. In contrast, the mean (+/- SD) 24-hour urinary calcium excretion in the patients with preeclampsia or hypertension with superimposed preeclampsia was significantly lower (42 +/- 29 and 78 +/- 49 mg) than that in normal pregnant women (313 +/- 140 mg per 24 hours), women with transient hypertension (248 +/- 139 mg per 24 hours), or women with chronic hypertension (223 +/- 41 mg per 24 hours) (P less than 0.0001). The hypocalciuria in the women with preeclampsia was associated with a decreased fractional excretion of calcium. Although the mean creatinine clearance was reduced in the women with preeclampsia, the range of values overlapped with those in the other groups. In contrast, we observed little or no overlap with respect to calcium excretion. We conclude that preeclampsia is associated with hypocalciuria due to increased tubular reabsorption of calcium. Measurement of calcium excretion may be useful in distinguishing preeclampsia from other forms of gestational hypertension.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3821810     DOI: 10.1056/NEJM198703193161204

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  13 in total

Review 1.  Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy.

Authors:  J M Moutquin; P R Garner; R F Burrows; E Rey; M E Helewa; I R Lange; S W Rabkin
Journal:  CMAJ       Date:  1997-10-01       Impact factor: 8.262

2.  A prospective study for the prediction of preeclampsia with urinary calcium level.

Authors:  Amitava Pal; Debobroto Roy; Sudhir Adhikary; Anita Roy; Mandira Dasgupta; Asok Kumar Mandal
Journal:  J Obstet Gynaecol India       Date:  2012-08-01

Review 3.  The hypertensive disorders of pregnancy.

Authors:  F Broughton Pipkin
Journal:  BMJ       Date:  1995-09-02

4.  First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia.

Authors:  Camille E Powe; Ellen W Seely; Sarosh Rana; Ishir Bhan; Jeffrey Ecker; S Ananth Karumanchi; Ravi Thadhani
Journal:  Hypertension       Date:  2010-08-23       Impact factor: 10.190

5.  Implications of vitamin D deficiency in pregnancy and lactation.

Authors:  Megan L Mulligan; Shaili K Felton; Amy E Riek; Carlos Bernal-Mizrachi
Journal:  Am J Obstet Gynecol       Date:  2009-10-20       Impact factor: 8.661

Review 6.  Hypertension in pregnancy.

Authors:  A Anyaegbunam; C Edwards
Journal:  J Natl Med Assoc       Date:  1994-04       Impact factor: 1.798

7.  Pre-eclampsia: is it all in the placenta?

Authors:  Harbindar Jeet Singh
Journal:  Malays J Med Sci       Date:  2009-01

Review 8.  [Vitamin D deficiency in pregnancy and its impact on the fetus, the newborn and in childhood].

Authors:  Marilyn Urrutia-Pereira; Dirceu Solé
Journal:  Rev Paul Pediatr       Date:  2015-02-07

Review 9.  Vitamin D and Inflammatory Cytokines in Healthy and Preeclamptic Pregnancies.

Authors:  David Barrera; Lorenza Díaz; Nancy Noyola-Martínez; Ali Halhali
Journal:  Nutrients       Date:  2015-08-04       Impact factor: 5.717

Review 10.  Vitamin D and the Promotion of Long-Term Metabolic Health from a Programming Perspective.

Authors:  Saranya Palaniswamy; Dylan Williams; Marjo-Riitta Järvelin; Sylvain Sebert
Journal:  Nutr Metab Insights       Date:  2016-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.